Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Shen

Showing results (431-440 of 465) with videos related to

Pageof 47
Sort By:
Neurogastroenterology and Motility|June 2, 2012
Platelet-derived growth factor receptor α (PDGFRα)-expressing "fibroblast-like cells" in diabetic and idiopathic gastroparesis of humansM Grover, C E Bernard, P J Pasricha, et al.
Immunity|August 20, 2024
An explainable language model for antibody specificity prediction using curated influenza hemagglutinin antibodiesYiquan Wang, Huibin Lv, Qi Wen Teo, et al.
Blood|January 17, 2009
Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomasMatthew J Frank, David W Dawson, Steven J Bensinger, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 10, 2001
Testosterone dose-response relationships in healthy young menS Bhasin, L Woodhouse, R Casaburi, et al.
Environmental Pollution (Barking, Essex : 1987)|December 2, 2004
Contamination of rivers in Tianjin, China by polycyclic aromatic hydrocarbonsZ Shi, S Tao, B Pan, et al.
JCI Insight|January 4, 2024
Sarm1 knockout prevents type 1 diabetic bone disease in females independent of neuropathyJennifer M Brazill, Ivana R Shen, Clarissa S Craft, et al.
Oncogene|January 30, 2007
Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomasD W Dawson, J S Hong, R R Shen, et al.
Journal of Medicinal Chemistry|August 10, 2001
6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinases with enhanced antitumor activityH R Tsou, N Mamuya, B D Johnson, et al.
Transplantation Proceedings|December 19, 2006
Characteristics of neoplasm occurrence and the therapeutic effect of sirolimus in South Chinese kidney transplant recipientsC X Wang, L S Liu, L Z Chen, et al.
Biochemical Pharmacology|March 23, 1999
Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with in vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785)C M Discafani, M L Carroll, M B Floyd, et al.
Pageof 47

Showing results (431-440 of 465) with videos related to

Sort By:
Pageof 47
Neurogastroenterology and Motility|June 2, 2012
Platelet-derived growth factor receptor α (PDGFRα)-expressing "fibroblast-like cells" in diabetic and idiopathic gastroparesis of humansM Grover, C E Bernard, P J Pasricha, et al.
Immunity|August 20, 2024
An explainable language model for antibody specificity prediction using curated influenza hemagglutinin antibodiesYiquan Wang, Huibin Lv, Qi Wen Teo, et al.
Blood|January 17, 2009
Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomasMatthew J Frank, David W Dawson, Steven J Bensinger, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 10, 2001
Testosterone dose-response relationships in healthy young menS Bhasin, L Woodhouse, R Casaburi, et al.
Environmental Pollution (Barking, Essex : 1987)|December 2, 2004
Contamination of rivers in Tianjin, China by polycyclic aromatic hydrocarbonsZ Shi, S Tao, B Pan, et al.
JCI Insight|January 4, 2024
Sarm1 knockout prevents type 1 diabetic bone disease in females independent of neuropathyJennifer M Brazill, Ivana R Shen, Clarissa S Craft, et al.
Oncogene|January 30, 2007
Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomasD W Dawson, J S Hong, R R Shen, et al.
Journal of Medicinal Chemistry|August 10, 2001
6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinases with enhanced antitumor activityH R Tsou, N Mamuya, B D Johnson, et al.
Transplantation Proceedings|December 19, 2006
Characteristics of neoplasm occurrence and the therapeutic effect of sirolimus in South Chinese kidney transplant recipientsC X Wang, L S Liu, L Z Chen, et al.
Biochemical Pharmacology|March 23, 1999
Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with in vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785)C M Discafani, M L Carroll, M B Floyd, et al.
Pageof 47